IN2012DN02729A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02729A
IN2012DN02729A IN2729DEN2012A IN2012DN02729A IN 2012DN02729 A IN2012DN02729 A IN 2012DN02729A IN 2729DEN2012 A IN2729DEN2012 A IN 2729DEN2012A IN 2012DN02729 A IN2012DN02729 A IN 2012DN02729A
Authority
IN
India
Application number
Inventor
Pnina Fishman
Original Assignee
Can Fite Biopharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42335564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN02729(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Can Fite Biopharma Ltd filed Critical Can Fite Biopharma Ltd
Publication of IN2012DN02729A publication Critical patent/IN2012DN02729A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
IN2729DEN2012 2009-09-06 2012-03-29 IN2012DN02729A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL200753A IL200753A (en) 2009-09-06 2009-09-06 Pharmaceutical composition comprising ib-meca for the treatment of psoriasis
PCT/IL2010/000729 WO2011027348A1 (en) 2009-09-06 2010-09-06 Pharmaceutical composition comprising a3 adenosine receptor agonist (ib-meca/cf-101) for treatment of psoriasis

Publications (1)

Publication Number Publication Date
IN2012DN02729A true IN2012DN02729A (en) 2015-09-11

Family

ID=42335564

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2729DEN2012 IN2012DN02729A (en) 2009-09-06 2012-03-29

Country Status (11)

Country Link
US (1) US8987228B2 (en)
EP (1) EP2475371B1 (en)
JP (1) JP5758896B2 (en)
KR (1) KR101741281B1 (en)
CN (2) CN104173364A (en)
DK (1) DK2475371T3 (en)
ES (1) ES2616882T3 (en)
HK (1) HK1204764A1 (en)
IL (1) IL200753A (en)
IN (1) IN2012DN02729A (en)
WO (1) WO2011027348A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL200753A (en) 2009-09-06 2015-06-30 Can Fite Biopharma Ltd Pharmaceutical composition comprising ib-meca for the treatment of psoriasis
WO2019045182A1 (en) 2017-08-31 2019-03-07 주식회사 이뮨메드 Composition for preventing and treating skin disorders including material which specifically binds to vimentin-derived peptide
IL272078A (en) 2020-01-16 2021-07-29 Can Fite Biopharma Ltd Cannabinoids for use in therapy
IL294409A (en) * 2022-06-29 2024-01-01 Can Fite Biopharma Ltd A pharmaceutical preparation that includes an agonist of the adenosine A3 receptor for the treatment of psoriasis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117878A (en) * 1998-02-24 2000-09-12 University Of Virginia 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
JP2004505048A (en) * 2000-08-01 2004-02-19 ユニバーシティー　オブ　ヴァージニア　パテント　ファウンデーション Use of selective adenosine A1 receptor agonists, antagonists and allosteric enhancers to treat angiogenesis
US20020179549A1 (en) 2001-06-04 2002-12-05 Chris Felcman System and method for mounting a keyboard and display assembly in a 1U rack space
AU2003282359A1 (en) 2002-11-19 2004-06-15 Can-Fite Biopharma Ltd. A3ar agonists for the treatment of inflammatory arthritis
WO2005063246A1 (en) 2003-12-29 2005-07-14 Can-Fite Biopharma Ltd. Method for treatment of multiple sclerosis
ATE402739T1 (en) 2004-12-02 2008-08-15 Can Fite Biopharma Ltd TREATMENT OF INFLAMMATION
WO2008056361A1 (en) * 2006-11-09 2008-05-15 Can-Fite Biopharma Ltd. A biological marker for psoriasis
IL184620A0 (en) * 2007-07-15 2008-01-20 Can Fite Biopharma Ltd Composition for the treatment of inflammation
IL200753A (en) 2009-09-06 2015-06-30 Can Fite Biopharma Ltd Pharmaceutical composition comprising ib-meca for the treatment of psoriasis

Also Published As

Publication number Publication date
HK1204764A1 (en) 2015-12-04
ES2616882T3 (en) 2017-06-14
KR101741281B1 (en) 2017-06-15
JP5758896B2 (en) 2015-08-05
JP2013503851A (en) 2013-02-04
WO2011027348A1 (en) 2011-03-10
EP2475371A1 (en) 2012-07-18
CN102481308A (en) 2012-05-30
CN104173364A (en) 2014-12-03
IL200753A (en) 2015-06-30
DK2475371T3 (en) 2017-03-06
IL200753A0 (en) 2010-06-30
US8987228B2 (en) 2015-03-24
EP2475371B1 (en) 2016-11-23
KR20120067994A (en) 2012-06-26
US20120165284A1 (en) 2012-06-28

Similar Documents

Publication Publication Date Title
BRPI0924307A2 (en)
BRPI1006562A2 (en)
BR112012008267A2 (en)
BRPI1006661A2 (en)
BR122021004633A2 (en)
BR112012012487A2 (en)
BR112012000665A2 (en)
BR122017024704A2 (en)
BR112012003853A2 (en)
BR112012012080A2 (en)
BR112012009446A2 (en)
BR112012009703A2 (en)
BRPI0924534A2 (en)
BRPI1005795A2 (en)
BR112012010357A2 (en)
BR112012007656A2 (en)
BR112012001263A2 (en)
BRPI1005817A2 (en)
BR112012014856A2 (en)
BRPI1004942A2 (en)
BR112012007654A2 (en)
BR112012005951A2 (en)
BR112012007672A2 (en)
BR112012009404A2 (en)
BR122017013721A2 (en)